Skip to main content
eScholarship
Open Access Publications from the University of California

UC Irvine

UC Irvine Previously Published Works bannerUC Irvine

Is BTKi or BCL2i preferable as first novel therapy in patients with CLL? The Case for BTKi

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View